Stem Cell Therapy to Skyrocket By 2017
Posted on: Thursday, 13 September 2007, 09:00 CDT
WALTHAM, Mass., Sept. 13 /PRNewswire/ -- Millennium Research Group (MRG) has conducted a detailed analysis of the stem cell therapy market in its US Markets for Stem Cell Therapies 2007 report. The analysis reveals that although the market for stem cell therapies is in its infancy, it will grow rapidly as products are approved in the US. Today, only two products are on the market, but by 2017, almost 90 are expected to be available.
Stem cells have regenerative capabilities, and promise lasting treatments for chronic disorders and potential cures for currently 'incurable' diseases. In 2007, the US stem cell therapies market earned over $25 million in revenues, with only two orthopedic products available in the US-Osiris Therapeutics' Osteocel, and Blackstone Medical's Trinity. Aside from these two products, the development of the US market for stem cell therapies is largely dependent on the success of clinical trials, regulatory approval, and public acceptance. The first products in the cardiovascular, diabetes, neurological, and tissue and organ stem cell therapy markets are expected to enter the market between 2009 and 2013. The entry of these products will open up a new realm of treatable disorders, offering hope to patients and vast market potential.
"This market has almost everything going its way", says Chris Schutz, senior analyst at MRG. "The big question mark however is the political and public support. The prevalence of potentially treatable disorders, unmet medical needs, rising health care costs, growth in the aging population, and the success of the first stem cell therapy products are all factors that will drive this market upward through 2017."
The US Markets for Stem Cell Therapies 2007 report includes coverage of companies offering or developing products for the stem cell therapy market, including Aastrom Biosciences, Advanced Cell Technologies, Arteriocyte, Blackstone Medical, Cytori Therapeutics, Geron, Harvest Technologies, International Stem Cell Corporation, and Osiris Therapeutics.
About Stem Cells
Stem cells are primal cells that are derived from highly proliferative tissues. These cells are precursors to every organ, tissue, and cell in the human body. Because of their universality and ability to repair or replace damaged tissue, stem cells have the potential to cure injuries and diseases such as orthopedic degenerative disease, cardiovascular disease, diabetes, neurological disease, cancer, retinal disease, and other chronic and autoimmune disorders.
About Millennium Research Group
Millennium Research Group (http://www.mrg.net/), a Decision Resources, Inc. company (http://www.decisionresources.com/), is the global authority on medical technology market intelligence and a leading provider of strategic information to the health care sector. Focused solely on the medical device, pharmaceutical, and biotechnology industries, the company provides its clients with the benefits of its specialized industry expertise through published reports and customized consulting services.
For more information, contact: Amy Krohn Millennium Research Group 416-364-7776 x101 akrohn@mrg.net
All company, brand, or product names contained in this document may be trademarks or registered trademarks of their respective holders.
Millennium Research Group
CONTACT: Amy Krohn of Millennium Research Group, +1-416-364-7776 x101 orakrohn@mrg.net
Web site: http://www.mrg.net/http://www.decisionresources.com/
Source: PRNewswire
Related Articles
- Reprocessed Catheters: A Growing Force In the US Electrophysiology Diagnostic Catheter Market, According to Millennium Research Group
- Global Spinal Nonfusion Market to Reach Almost $2 Billion By 2013, According to Millennium Research Group
- Despite Limitations the Asia Pacific Spinal Nonfusion Market Will See Double-Digit Growth Through 2013, According to Millennium Research Group
- Recent EMEA Regulations to Drive Autologous Chondrocyte Implantation Procedures Through 2013, According to Millennium Research Group
- Pharmacomechanical Thrombectomy Procedure Adoption to Accelerate Due to More Aggressive Treatment of Deep Vein Thrombosis, According to Millennium Research Group
- Broncus Technologies' Exhale Stent and Other New Devices to Prompt Robust Growth In Emphysema Treatment Market, According to Millennium Research Group
- Screening Programs to Drive European GI Videoscope Market Despite Economic Downturn, According to Millennium Research Group
- Millennium Research Group's New Perception Pulse Product Offers Clients an Innovative New Customer Behavior and Loyalty Tracking Tool
- Although the Health Care Market is Recession-Resistant, It Is Not Recession-Immune, According to Millennium Research Group's Medtech Economic Quarterly Publication
- Millennium Research Group Releases New Product: Medtech Economic Quarterly
 |
 |
User Comments (0)
RSS Feeds